Lauren Gardner's profile photo

Lauren Gardner

FDA Politics and Policy Reporter at POLITICO

Writer at Prescription Pulse Newsletter

FDA politics & policy reporter @POLITICO. Honorary 🇨🇦. 26.2 x5. It's pronounced "wooder." RTs ≠ ;) [email protected]

Featured in: Favicon politico.com Favicon msn.com Favicon yahoo.com (+1) Favicon politico.eu Favicon realclearpolitics.com Favicon rollcall.com Favicon thelancet.com Favicon politicopro.com Favicon newsbreak.com Favicon workdesign.com

Articles

  • How much money will the FDA get next year?

    1 day ago | politico.com | David Lim |Lauren Gardner

    Sen. John Hoeven, who's in charge of FDA appropriations, says that the agency will be adequately funded. | Francis Chung/POLITICO FDA APPROPS INCHES FORWARD — House appropriators advanced a bill to fund the FDA for fiscal 2026 on a party-line vote out of a subcommittee Thursday — but the bill has a long path ahead before it potentially becomes law. The topline number from the House bill aligns with President Donald Trump’s budget proposal, which sought $6.8 billion for the FDA.

  • WHO sounds the alarm as US measles cases mount

    1 day ago | politico.com | Lauren Gardner |Kelly Hooper

    The WHO's vaccine director is warning the Trump administration of dire consequences if it doesn't throw full-throated support behind the measles vaccine.

  • Fired HHS employees allege terminations were based on ‘error-ridden’ personnel records

    4 days ago | politico.com | Daniel Barnes |Lauren Gardner

    Agency personnel files listed incorrect performance ratings that were used to determine which employees would be laid off, according to a new lawsuit. People rally at the Health and Human Services headquarters to protest the policies of President Donald Trump and Elon Musk, Feb. 19, 2025, in Washington.

  • FDA’s early AI debut sparks questions

    4 days ago | politico.com | Lauren Gardner |David Lim

    FDA Commissioner Marty Makary says his agency's new AI tool can help reduce the time it takes to complete scientific reviews.

  • FDA denies ultra-rare drug but offers path to ‘yes’

    1 week ago | politico.com | Lauren Gardner |David Lim

    With help from Chelsea Cirruzzo While the FDA didn't approve a treatment for Barth syndrome, a rare, genetic disorder, it left the door open for future consideration. | Jose Luis Magana/AP Photo ANOTHER BLOW TO BARTH’S TREATMENT — The FDA rejected Stealth BioTherapeutics’ latest bid to market its proposed treatment for an ultra-rare genetic condition, though regulators have suggested a “path” toward accelerated approval, the company said Thursday.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
5K
Tweets
8K
DMs Open
Yes
Lauren Gardner
Lauren Gardner @Gardner_LM
7 May 25

State legislative efforts to loosen vaccinate mandates or to expand exemptions are gaining steam, even as the U.S. careens toward 1,000+ measles cases this year. My latest for The Fifty ⁦⁦@politico⁩ https://t.co/cy9SUiKV27

Lauren Gardner
Lauren Gardner @Gardner_LM
5 May 25

RT @BaltimoreBanner: Baltimore Banner wins Pulitzer Prize for coverage of overdose crisis https://t.co/qeQvhz46cs

Lauren Gardner
Lauren Gardner @Gardner_LM
1 May 25

My latest with ⁦@ChelseaCirruzzo⁩ — The biggest autism advocacy groups have condemned RFK Jr.’s rhetoric, but others representing the severest end of the spectrum say they’re happy for the recognition of their struggles, despite some concerns. https://t.co/lsA4W9gGIo